Sign in

NCT03063593Active, not recruiting

UK Infinity, Post-Market Clinical Follow-up Study

UK Multi-Centre, Observational, Post-Market Clinical Follow-up of the INFINITY® Total Ankle System

Source: ClinicalTrials.gov · Last updated 28 Aug 2026

Brief summary (registry, in English)

Study Title UK Post-Market Clinical Follow-Up Of The INFINITY® Total Ankle System Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY® Total Ankle System Number of Subjects 500 with 10 sites

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
15 Feb 2017
Start date
29 Apr 2016
Primary completion date
31 Dec 2029
Lead sponsor
Stryker Trauma and Extremities
NCT number
NCT03063593

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 29 Apr 2016 to the primary completion date, 31 Dec 2029
  • 12 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Subjects with an ankle condition, as determined by the investigator, to be an inappropriate candidate for a total ankle replacement;

Other

  • Subjects will be excluded from the study if they meet any of the following criteria:
  • Subjects requiring revision total ankle replacement of the ankle being considered for study

Who the study is looking for

  • Subjects to be included in the study must meet all of the following criteria:
  • Be 21 years of age at the time of surgery;
  • Diagnosed with unilateral and/or bilateral ankle joint disease;
  • Diagnosed with ankle joint damage from rheumatoid arthritis, post-traumatic, or degenerative arthritis; Willing and able to consent to participate (written, informed consent / witnessed verbal consent) Willing and able to attend the requested follow-up visits;
  • Subjects determined by the Investigator to be an appropriate candidate for the INFINITY® Total Ankle System

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (12)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University Hairmyres Hospital
Coordinator of this site? Confirm its status		BothwellUnited KingdomUnknown status
Royal Bournemouth Hosptial
Coordinator of this site? Confirm its status		BournemouthUnited KingdomUnknown status
North Bristol NHS Trust - Southmead Hospital
Coordinator of this site? Confirm its status		BristolUnited KingdomUnknown status
Royal Infirmary of Edinburgh
Coordinator of this site? Confirm its status		EdinburghUnited KingdomUnknown status
Royal Devon and Exeter NHS Foundation Trust
Coordinator of this site? Confirm its status		ExeterUnited KingdomUnknown status
Royal National Orthopaedic Hospital
Coordinator of this site? Confirm its status		MiddlesexUnited KingdomUnknown status
North Tyneside General Hospital
Coordinator of this site? Confirm its status		Newcastle upon TyneUnited KingdomUnknown status
Nottingham University Hospitals NHS Trust
Coordinator of this site? Confirm its status		NottinghamUnited KingdomUnknown status
RJAH Orthopaedic Hospital
Coordinator of this site? Confirm its status		OswestryUnited KingdomUnknown status
Sheffield Teaching Hospital
Coordinator of this site? Confirm its status		SheffieldUnited KingdomUnknown status
Torbay Hospital
Coordinator of this site? Confirm its status		TorquayUnited KingdomUnknown status
Wrightington Hospital
Coordinator of this site? Confirm its status		WiganUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.